51. 111In-Platelets and 99mTc-Human Polyclonal Immunoglobulin (HIG) Scintigraphy in Patients with Cerebrovascular Disease
- Author
-
L. Mairal, J. Rubio, Y. Ricart, J. Martin-Comin, Prat L, M. Roca, and X. Ferrer
- Subjects
Pathology ,medicine.medical_specialty ,medicine.diagnostic_test ,biology ,Endothelium ,business.industry ,Scintigraphy ,Immunoglobulin G ,medicine.anatomical_structure ,Angiography ,medicine ,biology.protein ,Platelet ,Antibody ,Receptor ,business ,Foam cell - Abstract
Atherosclerosis is the main cause of morbidity and mortality in the industrial countries. Although its ethiopatogenesis is not exactly known, it is accepted that the atheromatous plaque progresses in cycles of activity and quiescence. The process is initiated when the endothelium is injured and some of the cells die. Subsequently the necrotic area is covered by platelets and posteriorly new endothelial cells grow on this surface. These new endothelial cells have increased permeability to lipids and lipoproteins, and fatty material is deposited in the subendothelial space. This fatty material is very irritating and produce an inflammatory reaction. As a reaction macrophages migrate to the subendothelial space and phagocytize the fatty material and damaged endothelial cells. The macrophages full of lipids are called the foam cells and they express Fc receptors on the surface. Standard imaging techniques (sonography, doppler, computed tomography,angiography and magnetic nuclear resonance) used in the diagnosis of atherosclerotic disease allows identification of changes in wall thickness, in the turbulence of blood flow or in lumen diameter. Unfortunately all these changes appear once the atheromatous plaque is evolutionated, and they are not useful in the early diagnosis of lesions. In the search for a non invasive technique that allows the diagnostic of the atheromatous plaques in the early stages, different tracers have been used, the most significant being platelets3, 4, 5 and low density lipoproteinsl2, 15. 16. In this study we have used two different tracers the I I lin-platelets and the 99mTc-polyclonal immunoglobulin G (HIG), in patients with cerebro-vascular disease.
- Published
- 1994
- Full Text
- View/download PDF